A record of what Marketsmith India Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“Recommends buying Aster DM Healthcare in the range of ₹470–487, targeting a profit goal of ₹560 with a stop loss at ₹448, over a 2–3 month timeframe. This call is part of their 'Confirmed Uptrend' market status.”
Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%
Aster DM HealthcareBullishCalled 01 Apr 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.